What is The Viability Of Rhinoplasty For Different Age Groups?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Small but important picks can often be the first step towards improving our feelings about our appearance. Indeed, the nose’s shape defines facial balance and self-confidence. Moreover, the desire to have an improved appearance is not age-bound.  Rhinoplasty, or nose job, is emerging as the most adaptable cosmetic procedure due to its aesthetic and functional […]

The post What is The Viability Of Rhinoplasty For Different Age Groups? appeared first on Medical News Bulletin.

Tips for Maintaining Lifelong Oral Health and a Confident Smile

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Each one would be struggling to secure the optimal in their well being. But you might not be doing the same to your oral health, then that may not be possible. Individuals who have good oral health by keeping their teeth and gums clean and having their teeth checked on a regular basis will possess […]

The post Tips for Maintaining Lifelong Oral Health and a Confident Smile appeared first on Medical News Bulletin.

Tocotrienols vs. Tocopherols: Understanding the Vitamin E Difference

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

For​‍​‌‍​‍‌​‍​‌‍​‍‌ several decades, the bulk of research and supplementation of vitamin E centered nearly solely around tocopherols, most notably alpha-tocopherol, as the main forms to be given scientific and consumer attention. A limited viewpoint like this missed out on a whole new branch of the vitamin E family tree the tocotrienols – these are compounds […]

The post Tocotrienols vs. Tocopherols: Understanding the Vitamin E Difference appeared first on Medical News Bulletin.

FDA approves presbyopia contact lens with extended depth of focus

The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a press release from Bruno Vision Care.
It is the first daily disposable soft contact lens in the U.S. featuring extended depth of focus (EDOF), rather than a multifocal design, to correct presbyopia, according to the release. It allows for “continuous focus from near to far, with no patient cognitive adaptation period required,” Eddie Catalfamo, cofounder and CEO of Cataltheia Group, of which Bruno Vision Care is a subsidiary, told Healio.
The lens, made of vifilcon C

IOL calculators provide similar results in patients with LASIK history

Different IOL calculators provided similar results in patients with a history of LASIK surgery, according to a study published in the Journal of Refractive Surgery.
Thomas Kohnen, MD, PhD, and colleagues wrote that corneal refractive surgery has been shown to complicate the accuracy of IOL power calculations because the surgery alters the relationship between the anterior and posterior corneal refractive power.
“Formulas that predict the exact lens position from the corneal curvature are known to be inaccurate when corneal curvature and refractive power are altered by refractive surgery,” they

Trial Scorecard: CAVIAR

The CAVIAR trial evaluated safety and efficacy of the PCSK9 inhibitor alirocumab for prevention of cardiac allograft vasculopathy after heart transplantation.
Read Healio’s in-depth coverage of the CAVIAR trial.
CAVIAR included 114 patients who within 6 months after heart transplantation were randomly assigned to alirocumab (Praluent, Sanofi/Regeneron) plus rosuvastatin or rosuvastatin alone.
At 1 year, LDL levels decreased significantly in the alirocumab group, whereas there was no change in the rosuvastatin-only group.
However, the primary endpoint of change in coronary plaque volume from

Trial Scorecard: DECAF

The DECAF trial evaluated the effects of caffeinated coffee on risk for recurrent atrial fibrillation episodes in patients with persistent AF or atrial flutter undergoing cardioversion.
Read Healio’s in-depth coverage of the DECAF trial.
DECAF included 200 adults with persistent AF or atrial flutter who self-reported drinking about one cup of caffeinated coffee per day. After successful cardioversion, participants were randomly assigned to continue their regular coffee consumption or to abstain from caffeine for 6 months.
At 6 months, recurrence of AF or atrial flutter was 39% lower in the

What is the best option for hyperopic astigmatism after DMEK?

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
In this case, we have a patient with pseudophakia who underwent successful Descemet’s membrane endothelial keratoplasty for Fuchs’ dystrophy. Unfortunately, the patient developed hyperopic astigmatism following corneal surgery. He is now interested in refractive surgery to improve his uncorrected vision. He is expecting LASIK, but this might not be the best option.
This month, Rahul Tonk, MD, MBA,

Continuous anticoagulation may reduce VTE in trauma patients

PHOENIX — Continuous anticoagulation may effectively reduce the incidence of thromboembolic events in patients with orthopedic trauma, according to data presented at the Orthopaedic Trauma Association Annual Meeting.
“Many times, there are a lot of different protocols for each service, especially if a patient has multiple injuries and the orthopedic team has one protocol for anticoagulation and the general surgery trauma team has another. But this was very simple,” J. Tracy Watson, MD, professor in the department of orthopedic surgery at Saint Louis University School of

Resilient nursing workforce is key to high-quality dialysis care

In the past decade, we have seen tremendous advances in the prevention, treatment and management of chronic kidney disease from modalities like hemodiafiltration to therapeutics that slow disease progression.
We are also witnessing the integration of artificial intelligence and other technologies that are poised to transform how we deliver care.
Despite remarkable innovation in kidney care, one truth remains: The human connection between clinical staff and patients is the foundation of high-quality dialysis and is something technology cannot replicate.
More than 30 years ago, I started my